Proteasome inhibitor drugs

LD Fricker - Annual review of pharmacology and toxicology, 2020 - annualreviews.org
Proteasomes are large, multicatalytic protein complexes that cleave cellular proteins into
peptides. There are many distinct forms of proteasomes that differ in catalytically active …

Proteasome Inhibitor Drugs

LD Fricker - Annual Review of Pharmacology and …, 2020 - einstein.elsevierpure.com
Proteasomes are large, multicatalytic protein complexes that cleave cellular proteins into
peptides. There are many distinct forms of proteasomes that differ in catalytically active …

Proteasome Inhibitor Drugs

LD Fricker - Annual Review of Pharmacology and Toxicology, 2020 - cir.nii.ac.jp
抄録< jats: p> Proteasomes are large, multicatalytic protein complexes that cleave cellular
proteins into peptides. There are many distinct forms of proteasomes that differ in …

Proteasome Inhibitor Drugs.

LD Fricker - Annual Review of Pharmacology and Toxicology, 2019 - europepmc.org
Proteasomes are large, multicatalytic protein complexes that cleave cellular proteins into
peptides. There are many distinct forms of proteasomes that differ in catalytically active …

Proteasome Inhibitor Drugs

LD Fricker - Annual review of pharmacology and …, 2020 - pubmed.ncbi.nlm.nih.gov
Proteasomes are large, multicatalytic protein complexes that cleave cellular proteins into
peptides. There are many distinct forms of proteasomes that differ in catalytically active …